Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03306550Unknown
Randomised, open-label trial of salvianolate in stable angina (3 arms), sponsored by Xiyuan Hospital. Primary endpoints: Change of P-selection expression on platelet activation-dependent granule membrane, Change of PAC-1 expression on activated platelets and 2 more. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03306550.